US Patent 8815802 GLP-1 analogues and derivatives
Patent 8815802 was granted and assigned to Novo Nordisk on August, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 16, 2010
Date of Patent
August 26, 2014
Patent Application Number
13516312
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8815802 GLP-1 analogues and derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
